NDC 62135-501 – Ultramicrosize Griseofulvin
Griseofulvin 165 mg/1 · Tablet · Oral
Product NDC62135-501
Product details
- Brand name
- Ultramicrosize Griseofulvin
- Generic name
- Ultramicrosize Griseofulvin
- Labeler
- Chartwell RX, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA061996
- Marketed since
- April 6, 1982
- Listing expires
- December 31, 2026
- Pharmacologic class
- Tubulin Inhibiting Agent
Active ingredients
- Griseofulvin 165 mg/1
Uses, dosage, side effects and warnings for Ultramicrosize Griseofulvin →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62135-501-30 | 30 TABLET in 1 BOTTLE (62135-501-30) | Jan 30, 2025 |
Other Ultramicrosize Griseofulvin products
- 73308-435 Griseofulvin 165 mg/1 · Tablet · Ayurax, LLC.
- 62135-494 Griseofulvin 125 mg/1 · Tablet · Chartwell RX, LLC.
- 62135-495 Griseofulvin 250 mg/1 · Tablet · Chartwell RX, LLC.
- 23155-863 Griseofulvin 125 mg/1 · Tablet · Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
- 23155-864 Griseofulvin 250 mg/1 · Tablet · Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
- 42794-013 Griseofulvin 125 mg/1 · Tablet · Sigmapharm Laboratories, LLC
- 42794-014 Griseofulvin 250 mg/1 · Tablet · Sigmapharm Laboratories, LLC
- 0115-1724 Griseofulvin 125 mg/1 · Tablet, Coated · Amneal Pharmaceuticals of New York LLC
- 0115-1725 Griseofulvin 250 mg/1 · Tablet, Coated · Amneal Pharmaceuticals of New York LLC
- 0781-5827 Griseofulvin 125 mg/1 · Tablet, Coated · Sandoz Inc
- 0781-5828 Griseofulvin 250 mg/1 · Tablet, Coated · Sandoz Inc